That's a good point, but, it's still too much power in the hands of too few in the sector. If anything, Bayer should scoop up the small biopesticide players instead of MON to grab up the IP since I see growth in that arena.
You may have already discussed this. I'll have to do a search on the board for the related posts.
In Reply to 'DewDiligence'
Nixing the DOW-DD merger will lessen the impetus for regulators to block the Bayer-MON merger based on the argument that there are simply too few large players in the ag-tech industry.
As noted in my prior post, Bayer and MON have little overlap in their actual business lines.
News 
Market Data 
Discover 
